{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:51:18Z","timestamp":1792648278645,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic lupus erythematosus (SLE) can directly affect various part of the ocular system, but there was no comprehensive analysis of ophthalmic disorders of patients with SLE using population-based data. The aim of this study was to investigate the frequency and prevalence of ophthalmic disorders for ophthalmologist visits in adult patients with SLE and to evaluate the risk of dry eye syndrome, cataracts, glaucoma, episcleritis and scleritis, and retinal vascular occlusion in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Taiwan\u2019s National Health Insurance Research Database was used to assemble a SLE cohort consisting of newly diagnosed SLE between 2000 and 2012. A comparison cohort was also sampled from the same database and it consisted of 10 patients without SLE for each patient with SLE, based on frequency matching for sex, five-year age interval, and index year. Both cohorts were followed until either the study outcomes have occurred or the end of the follow-up period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with SLE (<jats:italic>n<\/jats:italic>\u2009=\u2009521) exhibited a significantly higher prevalence (68.1% vs. 60.5%, <jats:italic>P<\/jats:italic>\u2009=\u20090.001) and frequency (median 5.51 vs. 1.71 per 10\u2009years, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.001) for outpatient ophthalmologist visits compared with patients without SLE. The risk of dry eye syndrome (adjusted incidence rate ratio [IRR] 4.45, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.001), cataracts (adjusted IRR 3.18, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.001), and glaucoma (adjusted IRR 2.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.002) were significantly higher in patients with SLE. In addition, the risk of several SLE related ophthalmic disorders, including episcleritis and scleritis (adjusted IRR 6.11, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.001) and retinal vascular occlusion (adjusted IRR 3.81, <jats:italic>P<\/jats:italic>\u2009=\u20090.023) were significantly higher in patients with SLE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The increased risk of dry eye syndrome, cataracts, glaucoma, episcleritis and scleritis, and retinal vascular occlusion in patients with SLE deserves vigilance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01360-w","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T14:02:48Z","timestamp":1583935368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risks of ophthalmic disorders in patients with systemic lupus erythematosus \u2013 a secondary cohort analysis of population-based claims data"],"prefix":"10.1186","volume":"20","author":[{"given":"Chun-Shuo","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878\u201388.","journal-title":"Lancet"},{"key":"1360_CR2","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/rheumatology\/kem173","volume":"46","author":"RR Sivaraj","year":"2007","unstructured":"Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46:1757\u201362.","journal-title":"Rheumatology (Oxford)"},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","volume":"100","author":"S Silpa-archa","year":"2016","unstructured":"Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135\u201341.","journal-title":"Br J Ophthalmol"},{"key":"1360_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","volume":"18","author":"R Dammacco","year":"2018","unstructured":"Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18:135\u201349.","journal-title":"Clin Exp Med"},{"key":"1360_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1177\/0961203313502112","volume":"22","author":"L Zhang","year":"2013","unstructured":"Zhang L, Liu JJ, Li MT. Herpes simplex virus type 1 encephalitis and unusual retinitis in a patient with systemic lupus erythematosus. Lupus. 2013;22:1403\u20138.","journal-title":"Lupus"},{"key":"1360_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00296-011-2296-x","volume":"33","author":"RR El-Shereef","year":"2013","unstructured":"El-Shereef RR, Mohamed AS, Hamdy L. Ocular manifestation of systemic lupus erythematosus. Rheumatol Int. 2013;33:1637\u201342.","journal-title":"Rheumatol Int"},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/art.1780310904","volume":"31","author":"FJ Stafford-Brady","year":"1998","unstructured":"Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum. 1998;31:1105\u201310.","journal-title":"Arthritis Rheum"},{"key":"1360_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1442-9071.2001.00424.x","volume":"29","author":"SC Teoh","year":"2001","unstructured":"Teoh SC, Yap EY, Au Eong KG. Neuro-ophthalmological manifestations of systemic lupus erythematosus in Asian patients. Clin Exp Ophthalmol. 2001;29:213\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"1360_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1191\/096120300680199024","volume":"9","author":"QD Nguyen","year":"2000","unstructured":"Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9:288\u201398.","journal-title":"Lupus"},{"key":"1360_CR10","unstructured":"National Health Insurance Administration. National Health Insurance in Taiwan 2017\u20132018 Annual Report. Available from https:\/\/www.nhi.gov.tw\/DL.aspx?sitessn=293&u=LzAwMS9VcGxvYWQvMjkzL3JlbGZpbGUvMC8xNjEwNi8yMDE3LTIwMTjlhajmsJHlgaXlurfkv53pmqrlubTloLHngI%2fopr3mqpQucGRm&n=MjAxNy0yMDE45YWo5rCR5YGl5bq35L%2bd6Zqq5bm05aCx54CP6Ka95qqULnBkZg%3d%3d."},{"key":"1360_CR11","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.mehy.2014.08.017","volume":"83","author":"T Zhang","year":"2014","unstructured":"Zhang T, Xie X, Lu F. Primary open-angle glaucoma: neuroendocrine-immune disorder? Med Hypotheses. 2014;83:514\u20135.","journal-title":"Med Hypotheses"},{"key":"1360_CR13","first-page":"765","volume":"37","author":"J Shimazaki","year":"1995","unstructured":"Shimazaki J. Definition and diagnostic criteria of dry eye [in Japanese]. Ganka. 1995;37:765\u201370.","journal-title":"Ganka"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0961203310381515","volume":"20","author":"KC Hung","year":"2011","unstructured":"Hung KC, Hsueh PY, Wang NK, Su WW, Tan HY. Transient myopic shifting in systemic lupus erythematosus. Lupus. 2011;20:334\u20135.","journal-title":"Lupus"},{"key":"1360_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/09273948.2010.498655","volume":"18","author":"S Guerriero","year":"2010","unstructured":"Guerriero S, Cirac\u00ec L, Cardia G, Vetrugno M. Transient myopic shift as the presenting symptom of systemic lupus erythematosus: a UBM study. Ocul Immunol Inflamm. 2010;18:383\u20134.","journal-title":"Ocul Immunol Inflamm"},{"key":"1360_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2016.07.021","volume":"10","author":"HJ Lin","year":"2016","unstructured":"Lin HJ, Wei CC, Chang CY, Chen TH, Hsu YA, Hsieh YC, et al. Role of chronic inflammation in myopia progression: clinical evidence and experimental validation. EBioMedicine. 2016;10:269\u201381.","journal-title":"EBioMedicine"},{"key":"1360_CR17","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.3390\/ijerph110808112","volume":"11","author":"YP Hsiao","year":"2014","unstructured":"Hsiao YP, Tsai JD, Muo CH, Tsai CH, Sung FC, Liao YT, et al. Atopic diseases and systemic lupus erythematosus: an epidemiological study of the risks and correlations. Int J Environ Res Public Health. 2014;11:8112\u201322.","journal-title":"Int J Environ Res Public Health"},{"key":"1360_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00296-018-4083-4","volume":"38","author":"G Seth","year":"2018","unstructured":"Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, et al. Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int. 2018;38:1495\u2013501.","journal-title":"Rheumatol Int"},{"key":"1360_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12348-016-0081-4","volume":"6","author":"R Kharel Sitaula","year":"2016","unstructured":"Kharel Sitaula R, Shah DN, Singh D. Role of lupus retinopathy in systemic lupus erythematosus. J Ophthalmic Inflamm Infect. 2016;6:15.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1360_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1600-0714.1999.tb02047.x","volume":"28","author":"JL Jensen","year":"1999","unstructured":"Jensen JL, Bergem HO, Gilboe IM, Husby G, Ax\u00e9ll T. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med. 1999;28:317\u201322.","journal-title":"J Oral Pathol Med"},{"key":"1360_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00296-014-3129-5","volume":"35","author":"K Alderaan","year":"2015","unstructured":"Alderaan K, Sekicki V, Magder LS, Petri M. Risk factors for cataracts in systemic lupus erythematosus (SLE). Rheumatol Int. 2015;35:701\u20138.","journal-title":"Rheumatol Int"},{"key":"1360_CR22","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ophtha.2010.03.003","volume":"117","author":"HC Lin","year":"2010","unstructured":"Lin HC, Chien CW, Hu CC, Ho JD. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study. Ophthalmology. 2010;117:2088\u201395.","journal-title":"Ophthalmology"},{"key":"1360_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jmii.2014.05.001","volume":"49","author":"PC Chan","year":"2016","unstructured":"Chan PC, Yu CH, Yeh KW, Horng JT, Huang JL. Comorbidities of pediatric systemic lupus erythematosus: a 6-year nationwide population-based study. J Microbiol Immunol Infect. 2016;49:257\u201363.","journal-title":"J Microbiol Immunol Infect"},{"key":"1360_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","volume":"102","author":"M Sainz de la Maza","year":"1995","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687\u201392.","journal-title":"Ophthalmology"},{"key":"1360_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.74.3.163","volume":"74","author":"P Frith","year":"1990","unstructured":"Frith P, Burge SM, Millard PR, Wojnarowska F. External ocular findings in lupus erythematosus: a clinical and immunopathological study. Br J Ophthalmol. 1990;74:163\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1360_CR26","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/0961203317698050","volume":"26","author":"N Gao","year":"2017","unstructured":"Gao N, Li MT, Li YH, Zhang SH, Zhang SH, Dai RP, Zhang SZ, et al. Retinal vasculopathy in patients with systemic lupus erythematosus. Lupus. 2017;26:1182\u20139.","journal-title":"Lupus"},{"key":"1360_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/ard.48.5.358","volume":"48","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis. 1989;48:358\u201361.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01360-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:14:37Z","timestamp":1615421677000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01360-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01360-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]},"assertion":[{"value":"22 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan (No. B10104020), and was carried out in accordance with the ethical principles of the Declaration of Helsinki. The NHIRD files contain de-identified secondary data, the need for informed consent from individual subjects was waived. The National Health Insurance Research Database (NHIRD) was initially available for research purposes after a successful application from the National Health Insurance Administration, Ministry of Health and Welfare. After 2016, it is currently regulated by the Data Science Centre of the Ministry of Health and Welfare, Taiwan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}